Evaluation of Gynecological Acceptability of a Health Care Product

Status Completed

Clinical Trial Summary

The research will be conducted with a product for use in the intimate region in up to 75 research participants who will use the investigational product for 28 ± 2 days. Will be evaluated and followed up throughout the study by a gynecologist to verify the safety and effectiveness of the product and possible adverse events. The study will evaluate the non-interference of a topical use product on the intimate area, helping to preserve the natural defenses. In addition, the epithelial hydration and pH of the intimate area will be evaluated.

Clinical Trial Description

74 female participants, 18 to 59 years of age, healthy with complaints of vaginal dryness. The subjects will be submitted to gynecological evaluation in which pH measurements, hydration measurements and bacterioscopic collection will be performed. Then they will be guided to answer the questionnaires of Perceived Efficacy and Quality of Sexual Life. Next, participants will receive the product for home use, under real conditions of use, for 28 ± 2 days. After 28 ± 2 days of use, subjects will return to the institute, and undergo further evaluations with the gynecologist. New pH measurements, hydration measurements (chronometry), bacterioscopic collection will be performed and the participants will answer the Perceived Efficacy and Quality of Sexual Life questionnaires. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04247022
Study type	Interventional
Source	Herbarium Laboratorio Botanico Ltda
Contact
Status	Completed
Phase	N/A
Start date	April 9, 2021
Completion date	July 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00984399` - Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen	N/A
Completed	`NCT04079218` - Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial	Phase 4
Recruiting	`NCT05953090` - VALOR: Vaginal Atrophy & Long-term Observation of Recovery	N/A
Terminated	`NCT00816556` - A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis	Phase 3
Completed	`NCT00167921` - Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis	Phase 1
Completed	`NCT04327947` - Evaluation of Gynecological Acceptability of 3 Health Care Products	N/A
Recruiting	`NCT05118685` - Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis	Phase 1
Completed	`NCT03294538` - Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis	Phase 3
Completed	`NCT05058313` - Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy	N/A
Completed	`NCT02691936` - Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy	N/A
Completed	`NCT02995694` - A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis	Phase 3
Recruiting	`NCT06305494` - Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors
Completed	`NCT02195986` - A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis	Phase 3
Recruiting	`NCT03981458` - Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis	N/A
Completed	`NCT05396261` - a Flexible Wound Dressing for the Management of Genital Skin Conditions	N/A
Completed	`NCT02869165` - Vaginal and Urinary Microbiome Trial	Phase 4
Completed	`NCT02029053` - Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness	Phase 0
Not yet recruiting	`NCT06176820` - Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause	Phase 2/Phase 3
Recruiting	`NCT02733731` - The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis	Phase 1
Withdrawn	`NCT02460302` - Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy	Phase 2